A groundbreaking treatment, retatrutide, is sparking considerable buzz in the field of weight loss . This new therapy, a combined-action receptor agonist, appears to influence both GLP-1 and GIP hormones, potentially resulting to significant declines in body size and enhancing metabolic health . Early research studies have demonstrated impressive o